{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:47:16Z","timestamp":1793119636790,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Dr. DY Patil Vidyapeeth, Pune"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16057-4","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:35:53Z","timestamp":1780040153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of metformin on head and neck cancer: an umbrella review"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4174-907X","authenticated-orcid":false,"given":"Vini","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1338-0551","authenticated-orcid":false,"given":"Javier Flores","family":"Fraile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9004-9072","authenticated-orcid":false,"given":"Ankita","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8276-3682","authenticated-orcid":false,"given":"Mahati","family":"Bhadania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo","family":"Galletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"16057_CR1","doi-asserted-by":"publisher","first-page":"101945","DOI":"10.1016\/j.tranon.2024.101945","volume":"44","author":"L Zhu","year":"2024","unstructured":"Zhu L, Yang K, Ren Z, Yin D, Zhou Y. Metformin as anticancer agent and adjuvant in cancer combination therapy: Current progress and future prospect. Transl Oncol. 2024;44:101945. https:\/\/doi.org\/10.1016\/j.tranon.2024.101945.","journal-title":"Transl Oncol"},{"issue":"1","key":"16057_CR2","doi-asserted-by":"publisher","first-page":"298","DOI":"10.18632\/oncotarget.1628","volume":"5","author":"YC Lin","year":"2014","unstructured":"Lin YC, Wu MH, Wei TT, Lin YC, Huang WC, Huang LY, et al. Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress. Oncotarget. 2014;5(1):298\u2013308. https:\/\/doi.org\/10.18632\/oncotarget.1628.","journal-title":"Oncotarget"},{"issue":"3","key":"16057_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1158\/1940-6207.CAPR-14-0348","volume":"8","author":"D Madera","year":"2015","unstructured":"Madera D, Vitale-Cross L, Martin D, Schneider A, Molinolo AA, Gangane N, et al. Prevention of Tumor Growth Driven by PIK3CA and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3. Cancer Prev Res (Phila Pa). 2015;8(3):197\u2013207. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-14-0348.","journal-title":"Cancer Prev Res (Phila Pa)"},{"issue":"2","key":"16057_CR4","first-page":"159","volume":"34","author":"F Wang","year":"2014","unstructured":"Wang F, Xu J, Xia F, Liu Z, Zhao S, Liu H, et al. [Effects of metformin on human oral cancer KB cell proliferation and apoptosis in vitro]. Nan Fang Yi Ke Da Xue Xue Bao. 2014;34(2):159\u201363.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"6","key":"16057_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3978\/j.issn.2305-5839.2014.06.01","volume":"2","author":"J Kasznicki","year":"2014","unstructured":"Kasznicki J, Sliwinska A, Drzewoski J. Metformin in cancer prevention and therapy. Ann Transl Med. 2014;2(6):57. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2014.06.01.","journal-title":"Ann Transl Med"},{"key":"16057_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/ITT.S499605","volume":"14","author":"A Berbudi","year":"2025","unstructured":"Berbudi A, Khairani S, Tjahjadi A. Interplay Between Insulin Resistance and Immune Dysregulation in Type 2 Diabetes Mellitus: Implications for Therapeutic Interventions. ImmunoTargets Ther. 2025;14:359\u201382. https:\/\/doi.org\/10.2147\/ITT.S499605.","journal-title":"ImmunoTargets Ther"},{"key":"16057_CR7","doi-asserted-by":"publisher","first-page":"1455492","DOI":"10.3389\/fonc.2024.1455492","volume":"14","author":"M Hajimohammadebrahim-Ketabforoush","year":"2024","unstructured":"Hajimohammadebrahim-Ketabforoush M, Zali A, Shahmohammadi M, Hamidieh AA. Metformin and its potential influence on cell fate decision between apoptosis and senescence in cancer, with a special emphasis on glioblastoma. Front Oncol. 2024;14:1455492. https:\/\/doi.org\/10.3389\/fonc.2024.1455492.","journal-title":"Front Oncol"},{"key":"16057_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/636927","volume":"2013","author":"M Malek","year":"2013","unstructured":"Malek M, Aghili R, Emami Z, Khamseh ME. Risk of Cancer in Diabetes: The Effect of Metformin. ISRN Endocrinol. 2013;2013:1\u20139. https:\/\/doi.org\/10.1155\/2013\/636927.","journal-title":"ISRN Endocrinol"},{"issue":"1","key":"16057_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/ph16010115","volume":"16","author":"I Szymczak-Pajor","year":"2023","unstructured":"Szymczak-Pajor I, Drzewoski J, \u015awiderska E, Strycharz J, Gabryanczyk A, Kasznicki J, et al. Metformin Induces Apoptosis in Human Pancreatic Cancer (PC) Cells Accompanied by Changes in the Levels of Histone Acetyltransferases (Particularly, p300\/CBP-Associated Factor (PCAF) Protein Levels). Pharmaceuticals. 2023;16(1):115. https:\/\/doi.org\/10.3390\/ph16010115.","journal-title":"Pharmaceuticals"},{"issue":"5","key":"16057_CR10","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3390\/biology13050302","volume":"13","author":"E Amengual-Cladera","year":"2024","unstructured":"Amengual-Cladera E, Morla-Barcelo PM, Mor\u00e1n-Costoya A, Sastre-Serra J, Pons DG, Valle A, et al. Metformin: From Diabetes to Cancer\u2014Unveiling Molecular Mechanisms and Therapeutic Strategies. Biology. 2024;13(5):302. https:\/\/doi.org\/10.3390\/biology13050302.","journal-title":"Biology"},{"issue":"20","key":"16057_CR11","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1001\/jama.2022.6147","volume":"327","author":"PJ Goodwin","year":"2022","unstructured":"Goodwin PJ, Chen BE, Gelmon KA, Whelan TJ, Ennis M, Lemieux J, et al. Effect of Metformin vs Placebo on Invasive Disease\u2013Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial. JAMA. 2022;327(20):1963. https:\/\/doi.org\/10.1001\/jama.2022.6147.","journal-title":"JAMA"},{"issue":"24","key":"16057_CR12","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1158\/1078-0432.CCR-13-1787","volume":"19","author":"VE Zannella","year":"2013","unstructured":"Zannella VE, Dal Pra A, Muaddi H, McKee TD, Stapleton S, Sykes J, et al. Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response. Clin Cancer Res. 2013;19(24):6741\u201350. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-1787.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"16057_CR13","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jamaoncol.2021.2328","volume":"7","author":"T Tsakiridis","year":"2021","unstructured":"Tsakiridis T, Pond GR, Wright J, Ellis PM, Ahmed N, Abdulkarim B, et al. Metformin in Combination With Chemoradiotherapy in Locally Advanced Non\u2013Small Cell Lung Cancer: The OCOG-ALMERA Randomized Clinical Trial. JAMA Oncol. 2021;7(9):1333. https:\/\/doi.org\/10.1001\/jamaoncol.2021.2328.","journal-title":"JAMA Oncol"},{"issue":"9","key":"16057_CR14","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1001\/jamaoncol.2021.2318","volume":"7","author":"H Skinner","year":"2021","unstructured":"Skinner H, Hu C, Tsakiridis T, Santana-Davila R, Lu B, Erasmus JJ, et al. Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non\u2013Small Cell Lung Cancer: The NRG-LU001 Phase 2 Randomized Clinical Trial. JAMA Oncol. 2021;7(9):1324. https:\/\/doi.org\/10.1001\/jamaoncol.2021.2318.","journal-title":"JAMA Oncol"},{"issue":"2","key":"16057_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/02763869.2019.1588072","volume":"38","author":"JH Schiavo","year":"2019","unstructured":"Schiavo JH. PROSPERO: An International Register of Systematic Review Protocols. Med Ref Serv Q. 2019;38(2):171\u201380. https:\/\/doi.org\/10.1080\/02763869.2019.1588072.","journal-title":"Med Ref Serv Q"},{"key":"16057_CR16","unstructured":"Balk EM, Chung M, Hadar N, Patel K, Yu WW, Trikalinos TA et al. Accuracy of Data Extraction of Non-English Language Trials with Google Translate. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012. (AHRQ Methods for Effective Health Care). Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK95238\/. Cited 2026 Feb 5."},{"issue":"1","key":"16057_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Syst Rev"},{"issue":"3","key":"16057_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/edt.13028","volume":"41","author":"N Tewari","year":"2025","unstructured":"Tewari N, Devi P, Sampath S, Mathur VP, Tsilingaridis G, Wikstr\u00f6m A, et al. Comparative Effectiveness of Regenerative Endodontic Treatment Versus Apexification for Necrotic Immature Permanent Teeth With or Without Apical Periodontitis: An Umbrella Review. Dent Traumatol. 2025;41(3):263\u201382. https:\/\/doi.org\/10.1111\/edt.13028.","journal-title":"Dent Traumatol"},{"issue":"4","key":"16057_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jclinepi.2013.11.007","volume":"67","author":"D Pieper","year":"2014","unstructured":"Pieper D, Antoine SL, Mathes T, Neugebauer EAM, Eikermann M. Systematic review finds overlapping reviews were not mentioned in every other overview. J Clin Epidemiol. 2014;67(4):368\u201375. https:\/\/doi.org\/10.1016\/j.jclinepi.2013.11.007.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"16057_CR20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.oraloncology.2015.01.007","volume":"51","author":"DF R\u00eago","year":"2015","unstructured":"R\u00eago DF, Pavan LMC, Elias ST, De Luca Canto G, Guerra ENS. Effects of metformin on head and neck cancer: A systematic review. Oral Oncol. 2015;51(5):416\u201322. https:\/\/doi.org\/10.1016\/j.oraloncology.2015.01.007.","journal-title":"Oral Oncol"},{"issue":"2","key":"16057_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3892\/ol.2016.5526","volume":"13","author":"DF R\u00eago","year":"2017","unstructured":"R\u00eago DF, Elias ST, Amato AA, Canto GDL, Guerra ENS. Anti-tumor effects of metformin on head and neck carcinoma cell lines: A systematic review. Oncol Lett. 2017;13(2):554\u201366. https:\/\/doi.org\/10.3892\/ol.2016.5526.","journal-title":"Oncol Lett"},{"key":"16057_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.oraloncology.2018.08.015","volume":"85","author":"C Saka Herr\u00e1n","year":"2018","unstructured":"Saka Herr\u00e1n C, Jan\u00e9-Salas E, Estrugo Devesa A, L\u00f3pez-L\u00f3pez J. Protective effects of metformin, statins and anti-inflammatory drugs on head and neck cancer: A systematic review. Oral Oncol. 2018;85:68\u201381. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.08.015.","journal-title":"Oral Oncol"},{"issue":"1","key":"16057_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.pcd.2020.06.001","volume":"15","author":"K Zhang","year":"2021","unstructured":"Zhang K, Bai P, Dai H, Deng Z. Metformin and risk of cancer among patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Prim Care Diabetes. 2021;15(1):52\u20138. https:\/\/doi.org\/10.1016\/j.pcd.2020.06.001.","journal-title":"Prim Care Diabetes"},{"key":"16057_CR24","doi-asserted-by":"publisher","first-page":"850750","DOI":"10.3389\/fphar.2022.850750","volume":"13","author":"Y Jiao","year":"2022","unstructured":"Jiao Y, Liu D, Sun Y, Chen Z, Liu S. Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis. Front Pharmacol. 2022;13:850750. https:\/\/doi.org\/10.3389\/fphar.2022.850750.","journal-title":"Front Pharmacol"},{"issue":"1","key":"16057_CR25","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1007\/s12672-025-03327-z","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, He S, Li Z, Jiang N, Sun G. Mapping the current research landscape of metformin in cancer based on bibliometric analysis. Discov Oncol. 2025;16(1):1522. https:\/\/doi.org\/10.1007\/s12672-025-03327-z.","journal-title":"Discov Oncol"},{"issue":"3","key":"16057_CR26","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/coa.14271","volume":"50","author":"K Clements","year":"2025","unstructured":"Clements K, McMahon AD, Bhatti L, Smith C, Paterson C, Douglas CM, et al. Incidence Trends in Head and Neck Cancer Subsites: A National Population-Based Study (2001\u20132020). Clin Otolaryngol. 2025;50(3):474\u201384. https:\/\/doi.org\/10.1111\/coa.14271.","journal-title":"Clin Otolaryngol"},{"issue":"3","key":"16057_CR27","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3390\/cancers17030548","volume":"17","author":"M Wierzbicka","year":"2025","unstructured":"Wierzbicka M, Pietruszewska W, Maciejczyk A, Markowski J. Trends in Incidence and Mortality of Head and Neck Cancer Subsites Among Elderly Patients: A Population-Based Analysis. Cancers. 2025;17(3):548. https:\/\/doi.org\/10.3390\/cancers17030548.","journal-title":"Cancers"},{"issue":"5","key":"16057_CR28","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3390\/cancers16050982","volume":"16","author":"F Gaertner","year":"2024","unstructured":"Gaertner F, Preissner S, Heiland M, Preissner R, W\u00fcster J. Beneficial Effect of Metformin on the Five-Year Survival in about 40,000 Patients with Head and Neck Cancer. Cancers. 2024;16(5):982. https:\/\/doi.org\/10.3390\/cancers16050982.","journal-title":"Cancers"},{"issue":"7","key":"16057_CR29","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/odi.12206","volume":"21","author":"R Vander Broek","year":"2015","unstructured":"Vander Broek R, Mohan S, Eytan D, Chen Z, Van Waes C. The PI 3 K \/ A kt\/m TOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies. Oral Dis. 2015;21(7):815\u201325. https:\/\/doi.org\/10.1111\/odi.12206.","journal-title":"Oral Dis"},{"issue":"1","key":"16057_CR30","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1186\/s12885-019-6083-5","volume":"19","author":"YA Tsou","year":"2019","unstructured":"Tsou YA, Chang WD, Lu JJ, Wu TF, Chen HL, Chen CM, et al. The effect of metformin use on hypopharyngeal squamous cell carcinoma in diabetes mellitus patients. BMC Cancer. 2019;19(1):862. https:\/\/doi.org\/10.1186\/s12885-019-6083-5.","journal-title":"BMC Cancer"},{"issue":"1","key":"16057_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2407-14-173","volume":"14","author":"J Han","year":"2014","unstructured":"Han J, Fujisawa T, Husain SR, Puri RK. Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma. BMC Cancer. 2014;14(1):173. https:\/\/doi.org\/10.1186\/1471-2407-14-173.","journal-title":"BMC Cancer"},{"issue":"1","key":"16057_CR32","first-page":"135","volume":"25","author":"A Vazquez-Martin","year":"2011","unstructured":"Vazquez-Martin A, Oliveras-Ferraros C, Cuf\u00ed S, Del Barco S, Martin-Castillo B, Lopez-Bonet E, et al. The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells. Oncol Rep. 2011;25(1):135\u201340. PubMed PMID: 21109968.","journal-title":"Oncol Rep"},{"issue":"5","key":"16057_CR33","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.cmet.2010.03.014","volume":"11","author":"A Kalender","year":"2010","unstructured":"Kalender A, Selvaraj A, Kim SY, Gulati P, Br\u00fbl\u00e9 S, Viollet B, et al. Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner. Cell Metab. 2010;11(5):390\u2013401. https:\/\/doi.org\/10.1016\/j.cmet.2010.03.014.","journal-title":"Cell Metab"},{"key":"16057_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.oraloncology.2018.06.022","volume":"84","author":"WA Stokes","year":"2018","unstructured":"Stokes WA, Eguchi M, Amini A, Hararah MK, Ding D, McDermott JD, et al. Survival impact and toxicity of metformin in head and neck cancer: An analysis of the SEER-Medicare dataset. Oral Oncol. 2018;84:12\u20139. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.06.022.","journal-title":"Oral Oncol"},{"issue":"5","key":"16057_CR35","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1634\/theoncologist.2014-0426","volume":"20","author":"M Kwon","year":"2015","unstructured":"Kwon M, Roh JL, Song J, Lee SW, Kim SB, Choi SH, et al. Effect of Metformin on Progression of Head and Neck Cancers, Occurrence of Second Primary Cancers, and Cause-Specific Survival. Oncologist. 2015;20(5):546\u201353. https:\/\/doi.org\/10.1634\/theoncologist.2014-0426.","journal-title":"Oncologist"},{"issue":"1","key":"16057_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40463-019-0348-5","volume":"48","author":"DJ Lee","year":"2019","unstructured":"Lee DJ, McMullen CP, Foreman A, Huang SH, Lu L, Xu W, et al. Impact of metformin on disease control and survival in patients with head and neck cancer: A retrospective cohort study. J Otolaryngol - Head Neck Surg. 2019;48(1):34. https:\/\/doi.org\/10.1186\/s40463-019-0348-5.","journal-title":"J Otolaryngol - Head Neck Surg"},{"issue":"34","key":"16057_CR37","doi-asserted-by":"publisher","first-page":"55057","DOI":"10.18632\/oncotarget.10842","volume":"7","author":"TA Guimar\u00e3es","year":"2016","unstructured":"Guimar\u00e3es TA, Farias LC, Santos ES, de Carvalho Fraga CA, Orsini LA, de Freitas Teles L, et al. Metformin increases PDH and suppresses HIF-1\u03b1 under hypoxic conditions and induces cell death in oral squamous cell carcinoma. Oncotarget. 2016;7(34):55057\u201368. https:\/\/doi.org\/10.18632\/oncotarget.10842.","journal-title":"Oncotarget"},{"issue":"20","key":"16057_CR38","doi-asserted-by":"publisher","first-page":"7258","DOI":"10.3390\/jcm14207258","volume":"14","author":"T Buset","year":"2025","unstructured":"Buset T, Yanni A, Gerbaux M, Bouland C, Vanden Eynden X, Javadian R, et al. Biological Anti-Tumoral Mechanisms of Metformin in Head and Neck Squamous Cell Carcinomas: A Systematic Review. J Clin Med. 2025;14(20):7258. https:\/\/doi.org\/10.3390\/jcm14207258.","journal-title":"J Clin Med"},{"issue":"11","key":"16057_CR39","doi-asserted-by":"publisher","first-page":"e005632","DOI":"10.1136\/jitc-2022-005632","volume":"10","author":"M Crist","year":"2022","unstructured":"Crist M, Yaniv B, Palackdharry S, Lehn MA, Medvedovic M, Stone T, et al. Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition. J Immunother Cancer. 2022;10(11):e005632. https:\/\/doi.org\/10.1136\/jitc-2022-005632.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"16057_CR40","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3390\/ijms22041680","volume":"22","author":"M D\u0105browski","year":"2021","unstructured":"D\u0105browski M, Diabetes. Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors. Int J Mol Sci. 2021;22(4):1680. https:\/\/doi.org\/10.3390\/ijms22041680.","journal-title":"Int J Mol Sci"},{"key":"16057_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.sopen.2025.03.005","volume":"25","author":"M Justo","year":"2025","unstructured":"Justo M, Askin H, Mehta D, Benharash P. Pooled perspectives: Critical considerations for the modern meta-analysis. Surg Open Sci. 2025;25:5\u20137. https:\/\/doi.org\/10.1016\/j.sopen.2025.03.005.","journal-title":"Surg Open Sci"},{"issue":"7","key":"16057_CR42","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.2337\/dc14-0500","volume":"37","author":"S Suissa","year":"2014","unstructured":"Suissa S, Azoulay L. Metformin and Cancer: Mounting Evidence Against an Association. Diabetes Care. 2014;37(7):1786\u20138. https:\/\/doi.org\/10.2337\/dc14-0500.","journal-title":"Diabetes Care"},{"issue":"8","key":"16057_CR43","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jamaoto.2014.1258","volume":"140","author":"KS Tseng","year":"2014","unstructured":"Tseng KS, Lin C, Lin YS, Weng SF. Risk of Head and Neck Cancer in Patients With Diabetes Mellitus: A Retrospective Cohort Study in Taiwan. JAMA Otolaryngol Neck Surg. 2014;140(8):746. https:\/\/doi.org\/10.1001\/jamaoto.2014.1258.","journal-title":"JAMA Otolaryngol Neck Surg"},{"issue":"11","key":"16057_CR44","doi-asserted-by":"publisher","first-page":"e70467","DOI":"10.1002\/mco2.70467","volume":"6","author":"J Huang","year":"2025","unstructured":"Huang J, MSocSc SHC, MSocSc MC, Chan SC, Yuan J, Zhang L, et al. Incidence, Risk Factors, and Epidemiological Trends of Head and Neck Cancer: A Global Analysis. MedComm. 2025;6(11):e70467. https:\/\/doi.org\/10.1002\/mco2.70467.","journal-title":"MedComm"},{"issue":"6","key":"16057_CR45","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.1007\/s13277-014-1676-8","volume":"35","author":"M Aldea","year":"2014","unstructured":"Aldea M, Craciun L, Tomuleasa C, Berindan-Neagoe I, Kacso G, Florian IS, et al. Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery. Tumor Biol. 2014;35(6):5101\u201310. https:\/\/doi.org\/10.1007\/s13277-014-1676-8.","journal-title":"Tumor Biol"},{"issue":"2","key":"16057_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cmet.2015.01.003","volume":"21","author":"L He","year":"2015","unstructured":"He L, Wondisford FE. Metformin Action: Concentrations Matter. Cell Metab. 2015;21(2):159\u201362. https:\/\/doi.org\/10.1016\/j.cmet.2015.01.003.","journal-title":"Cell Metab"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16057-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16057-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16057-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:07:17Z","timestamp":1785755237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16057-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16057"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16057-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This umbrella review is based on previously published systematic reviews and meta-analyses and does not involve primary data collection from human subjects or animals.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"925"}}